Syndax Pharmaceuticals, Inc. (SNDX)
18.18
-0.64
(-3.40%)
USD |
NASDAQ |
Sep 11, 16:00
19.00
+0.82
(+4.51%)
After-Hours: 06:28
Syndax Pharmaceuticals Market Cap : 1.621B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.621B |
| September 10, 2026 | 1.678B |
| September 09, 2026 | 1.769B |
| September 08, 2026 | 1.778B |
| September 04, 2026 | 1.833B |
| September 03, 2026 | 1.844B |
| September 02, 2026 | 1.853B |
| September 01, 2026 | 1.792B |
| August 31, 2026 | 1.720B |
| August 28, 2026 | 1.742B |
| August 27, 2026 | 1.797B |
| August 26, 2026 | 1.791B |
| August 25, 2026 | 1.776B |
| August 24, 2026 | 1.745B |
| August 21, 2026 | 1.752B |
| August 20, 2026 | 1.761B |
| August 19, 2026 | 1.852B |
| August 18, 2026 | 1.775B |
| August 17, 2026 | 1.762B |
| August 14, 2026 | 1.769B |
| August 13, 2026 | 1.701B |
| August 12, 2026 | 1.765B |
| August 11, 2026 | 1.809B |
| August 10, 2026 | 1.816B |
| August 07, 2026 | 1.819B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.762B |
| August 05, 2026 | 1.776B |
| August 04, 2026 | 1.701B |
| August 03, 2026 | 1.715B |
| July 31, 2026 | 1.687B |
| July 30, 2026 | 1.725B |
| July 29, 2026 | 1.702B |
| July 28, 2026 | 1.738B |
| July 27, 2026 | 1.817B |
| July 24, 2026 | 1.843B |
| July 23, 2026 | 1.878B |
| July 22, 2026 | 1.952B |
| July 21, 2026 | 2.005B |
| July 20, 2026 | 1.974B |
| July 17, 2026 | 2.019B |
| July 16, 2026 | 2.011B |
| July 15, 2026 | 2.083B |
| July 14, 2026 | 2.137B |
| July 13, 2026 | 2.027B |
| July 10, 2026 | 2.091B |
| July 09, 2026 | 2.199B |
| July 08, 2026 | 2.175B |
| July 07, 2026 | 2.058B |
| July 06, 2026 | 1.955B |
| July 02, 2026 | 1.932B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viking Therapeutics, Inc. | 3.731B |
| Kura Oncology, Inc. | 1.013B |
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
| Anika Therapeutics, Inc. | 279.17M |
Market Cap Related Metrics
| PS Ratio | 6.328 |
| Price to Book Value | 107.34 |
| Price | 18.18 |
| Earnings Yield | -13.85% |